Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
Ecolab Inc. (ECL) Form 3 filed for Julie Whalen reports she is a director and that, as of the reporting event on 08/06/2025, she beneficially owns no securities of the issuer. The form is an initial Section 16 filing and was signed by an attorney-in-fact on 08/15/2025. This filing notifies investors that the newly reported insider currently holds no direct or indirect equity position to disclose.
Ecolab, Inc. (ECL) submitted a Form 144 proposing the sale of 807 shares of common stock with an aggregate market value of $223,232, to be offered on or about 08/13/2025 on the NYSE. The filing states the shares were acquired on 08/13/2025 through an employee stock option exercise, with 993 shares acquired and payment made via a broker-assisted cashless exercise. The broker listed is Morgan Stanley Smith Barney LLC - Executive Services. The filing reports 283,624,912 shares outstanding and notes Nothing to Report for securities sold in the past three months. The notice includes the seller's representation that they do not possess undisclosed material adverse information and references Rule 10b5-1 trading plans.
A Form 144 for Ecolab reports a proposed Rule 144 sale of 12,951 common shares through Merrill Lynch on the NYSE with an aggregate market value of $3,525,480.00. The filing lists total shares outstanding as 283,624,912 and an approximate sale date of 08/14/2025.
The shares were acquired as RSUs from Ecolab on 11/30/2018 and the payment is listed as cash. The filing reports no securities sold in the past three months and includes the standard attestation that the seller does not possess undisclosed material adverse information.